- Coordinator
- Universita Degli Studi Di Torino, Italy
- Runs
- 1 January 2025 to 30 June 2026
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 2 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101189458
What the project is doing
In the project's own words, from its summary on CORDIS.
Problem:In 2022, more than half a million lung cancer patients worldwide carrying KRAS mutations faced therapy resistance, a trend on the rise. Such cancers resist standard treatments and targeted therapies, leading to an average survival of 1.2 years post-treatment. The heterogeneous genetic background of KRAS-driven cancer adds further complexity, hindering personalized treatment due to resistance unpredictability. Solution:Our Proof Of Concept (PoC) project PREDICT provides a personalized treatment roadmap for KRAS-mutant lung cancer, available through knowledge and genetic tools generated thanks to our ERC CoG grant KARMA, which was aimed at the understanding of the molecular mechanisms regulating the formation of the functional KRAS complex at the cell membrane.
Using genetically-defined KRAS-mutant cell lines, our lab can facilitate direct comparisons of RAS-targeted treatments, including approved and trial drugs. This effort will empower clinicians to recommend effective strategies based on a patient's specific KRAS mutation, accounting for initial and potential acquired mutations and/or mechanisms of resistance. The model will evolve through in vitro testing, analyzing resistance mechanisms, and predicting therapies based on the patient's mutational landscape.
Importantly, our approach eliminates the need for animal models.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Torino | Torino | Italy | Coordinator |
| Day One Societa a Responsabilita Limitata | Roma Rm | Italy | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI